Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

THURSDAY, Nov. 14, 2024 (HealthDay News) -- Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn. “Recent research has shown that ...

Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn. "Recent research has shown that diabetes is not only a major risk factor for ...

DALLAS--(BUSINESS WIRE)--CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced a new report revealing 57% of ...

New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measures New data sought to evaluate the MiniMed™ 780G ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measures DUBLIN and FLORENCE, Italy, March 9, 2024 ...